Adult: Aortic ValveSutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis
Graphical abstract
Key Words
Abbreviations and Acronyms
Cited by (0)
Funded by LivaNova; PERSIST ClinicalTrials.gov number NCT02673697. LivaNova funded all trial-related activities and participated in site selection, data monitoring, trial management, and statistical analysis. Date and number of Ethics Committee/Institutional Review Board approval: March 2, 2016, Ethik-Kommission Nr. 15091 (Ethik-Kommission der Bayerischen Landesärztekammer BLAEK).
T.F. and R.L. contributed equally to this article.
- ∗
Olivier Fabre, MD, PhD, Frederic Pinaud, MD, PhD, Giovanni Troise, MD, Sami Kueri, MD, Matthias Siepe, MD, Nikolaos Bonaros, MD, PhD, Erwin Tan, MD, PhD, Martin Andreas, MD, PhD, Julio García-Puente, MD, Pierre Voisine, MD, Filip Rega, MD, PhD, Evaldas Girdauskas, MD, Elisabet Berastegui, MD, Thorsten Hanke, MD, Suzanne Kats, MD, Andrea Blasio, MD, Claudio Muneretto, MD, Alberto Repossini, MD, Salvatore Tribastone, MD, Laurent De Kerchove, MD, Elisa Mikus, MD, Marco Solinas, MD, Manfredo Rambaldini, MD, Sidney Chocron, MD, Dina De Bock, MD, Shaohua Wang, MD, Martin Grabenwoeger, MD, Ehud Raanani, MD, Mattia Glauber, MD, Gabriel Maluenda, MD, Basel Ramlawi, MD, Denis Bouchard, MD, Douglas Johnston, MD, Anno Diegeler, MD, Daniel Bitran, MD, Kevin Teoh, MD, André Vincentelli, MD, José Cuenca Castillo, MD, Bernard Albat, MD, Peter Oberwalder, MD, Mahesh Ramchandani, MD, David Heimansohn, MD. A complete list of the Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement investigators and contributors is provided in Online Data Supplement.